EXECUTIVE ENGAGEMENTS
POOL
909
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
182
Interactions with Platform & by Email
PARTICIPANTS
36
Unique # Participated
VALIDATIONS
12
Responses Validated*
COMPANIES
33
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
159
PAGES
222
EDITION
6
PRICE
USD 5600
CODE
MCP22773
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Single-Cell Genome Sequencing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at aCAGR of 14% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 14.4% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 13.5% CAGR for the next 7-year period.
The Single-Cell Genome Sequencing market in the U.S. is estimated at US$364 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$537.3 Million by the year 2027 trailing a CAGR of 13.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.5% and 11.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.
SELECT PLAYERS
10x Genomics; Agilent Technologies, Inc.; BGI; Bio-Rad Laboratories; DNA Electronics Ltd.; F Hoffmann-La Roche Ltd.; Fluidigm; Illumina, Inc.; Johnson & Johnson; Novogene; Oxford Nanopore Technologies; Pacific Biosciences; QIAGEN; Thermo Fisher Scientific, Inc.; Zephyrus Biosciences Inc.
SEGMENTS
» Product (Instruments, Reagents) » Technology (NGS, PCR, qPCR, Microarray, MDA) » End-Use (Academic & Research Labs, Biotech & Biopharma Companies, Clinics, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Single-Cell Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Single-Cell Genome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Single-Cell Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic & Research Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic & Research Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic & Research Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biotech & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biotech & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biotech & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for MDA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for MDA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for MDA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Single-Cell Genome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Single-Cell Genome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Single-Cell Genome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Single-Cell Genome Sequencing by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Single-Cell Genome Sequencing by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Single-Cell Genome Sequencing by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Single-Cell Genome Sequencing by End-Use - Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Single-Cell Genome Sequencing by End-Use - Percentage Breakdown of Value Sales for Clinics, Other End-Uses, Academic & Research Labs and Biotech & Biopharma Companies for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Single-Cell Genome Sequencing by Technology - Percentage Breakdown of Value Sales for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 33 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com